Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Incretin hormones--an update

    Holst, Jens Juul & Ørskov, Cathrine, 2001, In: Scandinavian Journal of Clinical & Laboratory Investigation. 234, p. 75-85 11 p.

    Research output: Contribution to journalReviewResearchpeer-review

  2. Published

    Gastrin-releasing peptide in the porcine pancreas

    Holst, Jens Juul & Poulsen, Steen Seier, May 1987, In: Gastroenterology. 92, 5 Pt 1, p. 1153-8 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    On the effects of glucagon-like peptide-1 on blood glucose regulation in normal and diabetic subjects

    Holst, Jens Juul, Toft-Nielsen, M. B., Ørskov, Cathrine, Nauck, M. & Willms, B., 26 Dec 1996, In: Annals of the New York Academy of Sciences. 805, p. 729-36 8 p.

    Research output: Contribution to journalReviewResearchpeer-review

  4. Published

    Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas

    Holst, Jens Juul & Poulsen, Steen Seier, Oct 1986, In: Endocrinology. 119, 4, p. 1467-75 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Vagal control of the release of somatostatin, vasoactive intestinal polypeptide, gastrin-releasing peptide, and HCl from porcine non-antral stomach

    Holst, Jens Juul, Skak-Nielsen, T., Ørskov, Cathrine & Seier-Poulsen, S., Aug 1992, In: Scandinavian Journal of Gastroenterology. 27, 8, p. 677-85 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    GRP nerves in pig antrum: role of GRP in vagal control of gastrin secretion

    Holst, Jens Juul & Poulsen, Steen Seier, Nov 1987, In: American Journal of Physiology (Consolidated). 253, 5 Pt 1, p. G643-9

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    GRP-producing nerves control antral somatostatin and gastrin secretion in pigs

    Holst, Jens Juul, Ørskov, Cathrine & Poulsen, Steen Seier, Dec 1987, In: American Journal of Physiology (Consolidated). 253, 6 Pt 1, p. G767-74

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    On the regulatory functions of neuropeptide Y (NPY) with respect to vascular resistance and exocrine and endocrine secretion in the pig pancreas

    Holst, Jens Juul, Ørskov, Cathrine, Knuhtsen, S., Sheikh, S. & Nielsen, O. V., Aug 1989, In: Acta Physiologica Scandinavica. 136, 4, p. 519-26 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Occurrence, distribution and motor effects of galanin in the porcine lower esophageal sphincter

    Holst, Jens Juul & Poulsen, Steen Seier, 1989, In: Digestion. 42, 3, p. 151-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Enteroglucagon

    Holst, Jens Juul, 2004, In Encyclopedia of Gatroenterology. USA: Elsevier, p. 709-715

    Research output: Chapter in Book/Report/Conference proceedingReport chapterResearch

  11. Published

    Glucagon-like peptides 1 and 2, enteroglucagon, glicentin and oxyntomodulin.

    Holst, Jens Juul & Kastin, A., 2006, Handbook of biologically active peptides. Amsterdam: Elsevier, p. 1057-1064 7 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  12. Published

    Treatment of Type 2 diabetes mellitus based on glucagon-like peptide-1

    Holst, Jens Juul, 1999, In: Exp. Opin. Invest. Drugs. 8, p. 1409-1415

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Obesity - did anything happen since leptin?

    Holst, Jens Juul, 1998, In: Ugeskrift for læger. 160, p. 1182-1184

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2

    Holst, Jens Juul, 2000, In: Review Regul Pept. 93, p. 45-51

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Incretin mimetics in the treatment of type 2 diabetes mellitus

    Holst, Jens Juul & Hughes, T., 2006, European Endocrine Disease 2006. London: Touch Briefings, p. 17-19 2 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  16. Published

    Nutrients of animal origin and function of gut hormones

    Holst, Jens Juul, 1998, Food and Health: Role of Animal Products. Paris: Elsevier, p. 13-22

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  17. Published

    Glucagon-like peptide-1 - a new hormone and a new drug

    Holst, Jens Juul, 1998, In: Ugeskrift for læger. 160, p. 2371-2377

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Glucagon-like peptide-1: From extract to agent. The Claude Bernard Lecture, 2005

    Holst, Jens Juul, 2006, In: Diabetologia. 49, 2, p. 253-260 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.

    Holst, Jens Juul, Gromada, K. & Rorsman, P., 1998, In: Pflugers Arch.. 435, p. 583-594

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    GLP-1 receptor argonists for the treatment of diabetes

    Holst, Jens Juul, 2005, In: International Diabetes Monitor. 17, p. 11-18

    Research output: Contribution to journalJournal articleResearch

  21. Published

    Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

    Holst, Jens Juul & Deacon, Carolyn F., 1998, In: Diabetes. 47, p. 1663-1670

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Role of GLP-1 analogues and DDP-IV inhibitors in the treatment of type 2 diabetes

    Holst, Jens Juul & Deacon, Carolyn F., 2006, In: Avances en Diabetologia. 22, 2, p. 115-125 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate

    Holst, Jens Juul, Hartmann, B., Gottschalck, I. B., Jeppesen, P. B., Miholic, J. & Henriksen, D. B., 2007, In: Scandinavian Journal of Gastroenterology. 42, 7, p. 814-820 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    New horizons in diabetes therapy

    Holst, Jens Juul & Deacon, Carolyn F., 2007, In: Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry. 7, 1, p. 49-55 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Regulatory peptides of the gastrointestinal tract

    Holst, Jens Juul, 2000, Small Bowel Disorders. London: Small Bowel Disorders, p. 96-115

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  26. Published

    On the treatment of diabetes mellitus with glucagon-like peptide-1.

    Holst, Jens Juul, Deacon, Carolyn F., Toft-Nielsen, M. & Bjerre-Knudsen, L., 1998, In: Annals of the New York Academy of Sciences. 865, p. 336-343

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential

    Holst, Jens Juul, 1999, In: Current Medicinal Chemistry. 6, p. 1005-1017

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. Published

    Regulatory Peptides of the Gut

    Holst, Jens Juul, 1998, Small Bowel Disorders. Kluwer Academic Publishers

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  29. Published

    Treatment of type 2 diabetes with glucagonlike peptide 1

    Holst, Jens Juul, 1998, In: Current Opinion in Endocrin. and Diabetes. 5, p. 108-115

    Research output: Contribution to journalJournal articleResearchpeer-review

  30. Published

    Incretin hormones - an update

    Holst, Jens Juul & Orskov, C., 2001, In: Scand J Clin Lab Inv. 61 Suppl. 234, p. 75-85

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. Published

    Glucagon-like peptide-1 (GLP-1): An intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential

    Holst, Jens Juul, 1999, In: Trends in Endocrinology and Metabolism. 10, p. 229-235

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. Published

    Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver-α-Cell Axis

    Holst, Jens Juul, Albrechtsen, Nicolai Jacob Wewer, Pedersen, Jens & Knop, Filip Krag, Feb 2017, In: Diabetes. 66, 2, p. 235-240 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. Published

    IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test

    Holst, Jens Juul, Buse, J. B., Rodbard, H. W., Linjawi, S., Woo, V. C., Boesgaard, T. W., Kvist, K. & Gough, S. C., Mar 2016, In: Journal of Diabetes Science and Technology. 10, 2, p. 389-97 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. Published

    Gut hormones and gastric bypass

    Holst, Jens Juul, 2016, In: Cardiovascular Endocrinology. 5, 3, p. 69-74 6 p.

    Research output: Contribution to journalReviewResearchpeer-review

  35. Published

    Methods and Guidelines for Measurement of Glucagon in Plasma

    Holst, Jens Juul & Albrechtsen, Nicolai Jacob Wewer, 2019, In: International Journal of Molecular Sciences (Online). 20, 10 p., 5416.

    Research output: Contribution to journalReviewResearchpeer-review

  36. Published

    What is Diabetes Remission?

    Holst, Jens Juul & Madsbad, Sten, 2021, In: Diabetes Therapy. 12, p. 641-646 6 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  37. Published

    Oxyntomodulin: actions and role in diabetes

    Holst, Jens Juul, Albrechtsen, Nicolai Jacob Wewer, Gabe, M. B. N. & Rosenkilde, M. M., 2018, In: Peptides. 100, p. 48-53 6 p.

    Research output: Contribution to journalReviewResearchpeer-review

  38. Published

    Secretion and Impact of Gut Hormones in Obesity and Diabetes

    Holst, Jens Juul, 2023, Encyclopedia of Cell Biology: Systems, Translational and Specialized Cell Aspects of Cell Biology. Bradshaw, R. A., Hart, G. W. & Stahl, P. D. (eds.). 2 ed. Elsevier, Vol. 6. p. 543-550 8 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  39. Published

    Physiology of the Incretin Hormones, GIP and GLP-1-Regulation of Release and Posttranslational Modifications

    Holst, Jens Juul, Albrechtsen, Nicolai Jacob Wewer, Rosenkilde, Mette & Deacon, Carolyn F., 2019, In: Comprehensive Physiology. 9, 4, p. 1339-1381

    Research output: Contribution to journalJournal articleResearchpeer-review

  40. Published

    The pathogenesis of non-insulin dependent diabetes mellitus involves a defective expression of the GIP receptor.

    Holst, Jens Juul, Gromada, J. L. & Nauck, M. A., 1997, In: Diabetologia. 40, p. 984-986

    Research output: Contribution to journalJournal articleResearchpeer-review

  41. Published

    Glucagon-like peptide-1 mediates the therapeutic actions of Dpp-IV inhibitors

    Holst, Jens Juul & Deacon, Carolyn F., 2005, In: Diabetologia. 48, p. 612-615

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published

    Discovery of the GI Effects of GLP-1: An Historical Perspective

    Holst, Jens Juul, 2022, In: Digestive Diseases and Sciences. 67, p. 2716-2720

    Research output: Contribution to journalReviewResearchpeer-review

  43. Published

    Regulation of glucagon secretion by incretins

    Holst, Jens Juul, Christensen, M., Lund, A., de Heer, J., Svendsen, B., Kielgast, U. & Knop, Filip Krag, Oct 2011, In: Diabetes, Obesity and Metabolism. 13 , Suppl 1, p. 89-94 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  44. Published

    The incretin system and its role in type 2 diabetes mellitus

    Holst, Jens Juul, Vilsbøll, Tina & Deacon, Carolyn F., 2008, In: Molecular and Cellular Endocrinology. 297, 1-2, p. 127-136 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  45. Published

    Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate

    Holst, Jens Juul, Hartmann, Bolette, Gottschalck, I. B., Jeppesen, Palle Bekker, Miholic, J. & Henriksen, D. B., Jul 2007, In: Scandinavian Journal of Gastroenterology. 42, 7, p. 814-20 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  46. Published

    Enteroglucagon

    Holst, Jens Juul, 1997, In: Annual Reviews of Physiology. 59, p. 257-272

    Research output: Contribution to journalJournal articleResearchpeer-review

  47. Published

    Glucagon-like peptide-1 - et nyt hormon med mulig anvendelse i diabetesbehandlingen

    Holst, Jens Juul, 1993, In: Tidsskrift for Diabetesbehandling. 3, p. 33-39

    Research output: Contribution to journalJournal articleResearch

  48. Published

    The incretin approach for diabetes treatment: modulation of islet hormone release by GLP-1 agonism.

    Holst, Jens Juul & Ørskov, Cathrine, 2004, In: Diabetes. 53 Suppl 3, p. S197-204

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    7 Heterogeneity of Islet Hormones

    Holst, Jens Juul, Ørskov, C. & Bersani, M., 1991, The Endocrine Pancreas. New York: Raven Press, p. 125-152

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  50. Published

    Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist?

    Holst, Jens Juul, 2019, In: The Lancet. 394, 10192, p. 4-6

    Research output: Contribution to journalEditorialResearchpeer-review

  51. Published

    The physiology and pharmacology of incretins in type 2 diabetes mellitus

    Holst, Jens Juul, 2008, In: Diabetes, Obesity and Metabolism. 10, Suppl. 3, p. 14-21 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  52. Published

    Human Glucagon-like peptide-1, - six important topics.

    Holst, Jens Juul, 1995, Gastrointestinal Tract and Endocrine System.. Dordrecht/Boston/London: Kluwer Academic Publishers, p. 537-546

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  53. Published

    GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists

    Holst, Jens Juul & Rosenkilde, M. M., 2020, In: Journal of Clinical Endocrinology & Metabolism. 105, 8, p. E2710-E2716 7 p.

    Research output: Contribution to journalReviewResearchpeer-review

  54. Published

    Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005

    Holst, Jens Juul, Feb 2006, In: Diabetologia. 49, 2, p. 253-60 8 p.

    Research output: Contribution to journalJournal articleCommunication

  55. Published

    GLP-1 - Incretin and pleiotropic hormone with pharmacotherapy potential. Increasing secretion of endogenous GLP-1 for diabetes and obesity therapy

    Holst, Jens Juul, Jepsen, Sara Lind & Modvig, Ida Marie, 2022, In: Current Opinion in Pharmacology. 63, p. 1-7 102189.

    Research output: Contribution to journalJournal articleResearchpeer-review

  56. Published

    Overview of incretin hormones.

    Holst, Jens Juul & Lasalle, J., 2008, In: Journal of Family Practice. 57, 9, p. 53-59

    Research output: Contribution to journalJournal articleResearchpeer-review

  57. Published

    Incretin hormones as a target for therapy

    Holst, Jens Juul, 2016, Handbook of Incretin-based Therapies in Type 2 Diabetes. Gough, S. (ed.). Springer, p. 11-30

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  58. Published

    Kardiale virkninger af glukagonlignende peptid 1

    Holst, Jens Juul, 11 Oct 2010, In: Ugeskrift for Laeger. 172, 41, p. 2821 1 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  59. Published

    Role of classical and peptidergic neurotransmitters in insulin secretion

    Holst, Jens Juul, 1991, Nutrient Regulation of Insulin Secretion. Portland Press

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  60. Published

    Implementation of GLP-1 based therapy of type 2 diabetes mellitus using DPP-IV inhibitors.

    Holst, Jens Juul, 2003, In: Advances in Experimental Medicine and Biology. 524, p. 263-79 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  61. Published

    Transmitters in the control of gastrin and acid secretion in the pig stomach

    Holst, Jens Juul, Nørre Ramussen, T., Schmidt, P. & Poulsen, S. S., 1993, Gastrin. New York: Raven Press, p. 243-258

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  62. Published

    For debate: Are antidiabetic actions of DPP-IV inhibitors mediated by glucagon-like peptide- 1?

    Holst, Jens Juul & Deacon, Carolyn F., 2005, In: Diabetologia. 48, p. 612-615

    Research output: Contribution to journalJournal articleResearchpeer-review

  63. Published

    Enhancing insulin secretion: novel approaches to glucose control

    Holst, Jens Juul, 2004, In: Diabetes Voice. 49, p. 20-22

    Research output: Contribution to journalJournal articleResearchpeer-review

  64. Published

    Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1.

    Holst, Jens Juul, 2002, In: Diabetes - Metabolism: Research and Reviews (Print Edition). 18, 6, p. 430-41 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  65. Published

    Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.

    Holst, Jens Juul, 2004, In: Expert Opinion on Emerging Drugs. 9, 1, p. 155-66 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  66. Published

    The Gut: A Key to the Pathogenesis of Type 2 Diabetes?

    Holst, Jens Juul, Pedersen, Jens, Albrechtsen, Nicolai Jacob Wewer & Knop, Filip Krag, Aug 2017, In: Metabolic Syndrome and Related Disorders. 15, 6, p. 259-262 4 p.

    Research output: Contribution to journalReviewResearchpeer-review

  67. Published

    Neuroprotective properties of GLP-1: theoretical and practical applications

    Holst, Jens Juul, Burcelin, R. & Nathanson, E., 2011, In: Current Medical Research and Opinion. 27, 3, p. 547-58 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  68. Published

    Will GLP-1 treatment increase blood pressure? Summary and comment

    Holst, Jens Juul, 2003, In: Diabetes Monitor. 15, p. 15-17

    Research output: Contribution to journalJournal articleResearchpeer-review

  69. Published

    Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor

    Holst, Jens Juul & Madsbad, Sten, Jul 2016, In: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 12, 6, p. 1236-42 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  70. Published

    Assays for Peptide Products of Somatostatin Gene Expression

    Holst, Jens Juul & Bersani, M., 1991, In: Methods in Neurosciences. 5, p. 3-22

    Research output: Contribution to journalJournal articleResearchpeer-review

  71. Published

    From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy

    Holst, Jens Juul, 2019, In: Frontiers in Endocrinology. 10, 10 p., 260.

    Research output: Contribution to journalReviewResearchpeer-review

  72. Published

    Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

    Holst, Jens Juul & Deacon, Carolyn F., Apr 2005, In: Diabetologia. 48, 4, p. 612-5 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  73. Published

    Searching for the physiological role of glucose-dependent insulinotropic polypeptide

    Holst, Jens Juul, Windeløv, Johanne Agerlin, Boer, G. A., Pedersen, Jens, Svendsen, B., Christensen, M., Torekov, Signe Sørensen, Asmar, M., Hartmann, Bolette & Nissen, A., 1 Apr 2016, In: Journal of Diabetes Investigation. 7, S1, p. 8-12 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  74. Published

    Glucagon 100 years. Important, but still enigmatic

    Holst, Jens Juul, 2023, In: Peptides. 161, 6 p., 170942.

    Research output: Contribution to journalJournal articleResearchpeer-review

  75. Published

    Glucagon-like peptide-1 (GLP-1) - A newly discovered Gl Hormone. Review.

    Holst, Jens Juul, 1994, In: Today in Medicine. Gastroenterology. 107, p. 1848-1855

    Research output: Contribution to journalJournal articleResearchpeer-review

  76. Published

    Posttranslational processing of proglucagon and postsecretory fate of proglucagon products.

    Holst, Jens Juul, Ørskov, C., Hartmann, B. & Deacon, Carolyn F., 1997, The Insulinotropic Gut Hormone Glucagon-like Peptide-1.. Basel: Karger, p. 24-48

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  77. Published

    Chap.10. Degradation of glucagons

    Holst, Jens Juul, 1991, Degradation of Bioactive Substances: Physiology and Pathophysiology. Boca Raton, Florida: CRC Press, p. 167-180

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  78. Published

    Actions of glucagon-like peptide-1 receptor ligands in the gut

    Holst, Jens Juul, Andersen, Daniel Bjørklund & Grunddal, Kaare Villum, 2022, In: British Journal of Pharmacology. 179, 4, p. 727-742

    Research output: Contribution to journalReviewResearchpeer-review

  79. Published

    Roles of the Gut in Glucose Homeostasis

    Holst, Jens Juul, Gribble, F., Horowitz, M. & Rayner, C. K., Jun 2016, In: Diabetes Care. 39, 6, p. 884-92 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  80. Published

    GLP-1 receptor agonists: targeting both hyperglycaemia and disease processes in diabetes

    Holst, Jens Juul & Seino, Y., 2009, In: Diabetes Research and Clinical Practice. 85, 1, p. 1-3 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  81. Published

    Semaglutide seems to be more effective the other GLP-1Ras

    Holst, Jens Juul & Madsbad, Sten, Dec 2017, In: Annals of Translational Medicine. 5, 24, 5 p., 505.

    Research output: Contribution to journalComment/debateResearch

  82. Published

    The incretin system in healthy humans: The role of GIP and GLP-1

    Holst, Jens Juul, 2019, In: Metabolism. 96, p. 46-55

    Research output: Contribution to journalJournal articleResearchpeer-review

  83. Published

    Glucagon-like peptide 1 - a new hormone which may change the treatment of non-insulin dependent diabetes mellitus

    Holst, Jens Juul & Ørskov, C., 1992, In: MedView. 6, p. 259-263

    Research output: Contribution to journalJournal articleResearchpeer-review

  84. Published

    Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.

    Holst, Jens Juul & Gromada, J., 2004, In: American Journal of Physiology: Endocrinology and Metabolism. 287, 2, p. E199-206

    Research output: Contribution to journalJournal articleResearchpeer-review

  85. Published

    Effect of intestinal inhibitory peptides on vagally induced secretion from isolated perfused porcine pancreas

    Holst, Jens Juul, Rasmussen, T. N., Harling, H. & Schmidt, P., 1993, In: Pancreas. Vol. 8, no. 1, p. 80-87

    Research output: Contribution to journalJournal articleResearchpeer-review

  86. Published

    Isolated organs as replacements for vertebrate animals

    Holst, Jens Juul, 1994, Handbook of Laboratory Animal Science. USA: CRC Press, p. 397-408

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  87. Published

    Is there a place for incretin therapies in obesity and prediabetes?

    Holst, Jens Juul & Deacon, Carolyn F., 13 Feb 2013, In: Trends in Endocrinology and Metabolism. 24, 3, p. 145-152 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  88. Published

    Neural regulation of pancreatic exocrine funktion

    Holst, Jens Juul, 1993, In: The Pancreas: Biology, Pathobiology an Disease. p. 381-402

    Research output: Contribution to journalJournal articleResearchpeer-review

  89. Published

    Glucagon and other proglucagon-derived peptides

    Holst, Jens Juul & Ørskov, Cathrine, 1994, Gut Peptides: Biochemistry and Physiology. New York: Raven Press, p. 305-340

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  90. Published

    Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: focus on bile acid sequestrants

    Holst, Jens Juul & McGill, M. A., 2012, In: Clinical Drug Investigation. 32, 1, p. 1-14 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  91. Published

    Glucagon-like peptides 1 and 2, enteroglucagon, glicentin and oxyntomodulin

    Holst, Jens Juul, Deacon, Carolyn F., Hartmann, Bolette & Pedersen, Jens, 2013, Handbook of Biologically Active Peptides . Kastin, AJ. (ed.). 2 ed. Elsevier, p. 1241-1250 10 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterEducation

  92. Published

    Erratum to semaglutide seems to be more effective the other GLP-1Ras

    Holst, Jens Juul & Madsbad, Sten, 2018, In: Annals of Translational Medicine. 6, 3, p. 74

    Research output: Contribution to journalJournal articleResearchpeer-review

  93. Published

    Non-insulin-dependent diabetes mellitus - new drugs?

    Holst, Jens Juul, 1997, In: Drug Discovery Today. 2, p. 128-129

    Research output: Contribution to journalJournal articleResearchpeer-review

  94. Published

    Somatostatin is an essential paracrine link in acid inhibition of gastrin secretion

    Holst, Jens Juul, Ørskov, Cathrine & Poulsen, S. S., 1992, In: Digestion. 51, p. 95-102

    Research output: Contribution to journalJournal articleResearchpeer-review

  95. Published

    Incretin based therapies: do they hold their promise?

    Holst, Jens Juul, 2012, In: Journal of Diabetes. 4, 1, p. 4-7 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  96. Published

    Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus.

    Holst, Jens Juul & Deacon, Carolyn F., 2004, In: Current Opinion in Pharmacology. 4, 6, p. 589-96 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  97. Published

    Neuromediators in the control of pancreatic secretion

    Holst, Jens Juul, 1993, Neuromediators in the control of pancreatic secretion. Torun: Polish Physiological Society, p. 72-78

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  98. Published

    New Lessons from the gut: Studies of the role of gut peptides in weight loss and diabetes resolution after gastric bypass and sleeve gastrectomy

    Holst, Jens Juul, Madsbad, Sten, Bojsen-Møller, Kirstine Nyvold, Dirksen, C. & Svane, M., 2024, In: Peptides. 176, 9 p., 171199.

    Research output: Contribution to journalReviewResearchpeer-review

  99. Published

    Gut hormones and intestinal function

    Holst, Jens Juul & Schmidt, P., 1994, The Gut as an Endocrine Organ. Clinics in Endocrinology and Metabolism, Vol 8. Bailliere, p. 137-164

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  100. Published

    What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists?

    Holst, Jens Juul, 2021, In: Cell Reports Medicine. 2, 5, 2 p., 100284.

    Research output: Contribution to journalComment/debateResearch

Previous 1...3 4 5 6 7 8 9 10 ...19 Next

ID: 4207